TUMORANTIGENPEPTIDE

European patent · EP3199627 · Deleted

Register entry

Publication number
EP3199627
Application number
EP15843390
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 24, 2015
Published
Aug 2, 2017
Granted
Apr 7, 2021
Deleted
Apr 29, 2022
Reason
Annual fee unpaid
IPC classes
C12N 15/00 (2006.01)
A61K 35/76 (2015.01)
A61K 39/00 (2006.01)
A61K 48/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
C07K 7/06 (2006.01)
C12N 5/10 (2006.01)
C12N 15/09 (2006.01)
C07K 14/82 (2006.01)
Priority
JP 2014194391 24.09.2014
PCT application
PCT/JP2015/076994 24.09.2015
PCT publication
WO2016/047715 31.03.2016
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 29, 2022

    Deleted, fee unpaid

    Published in Swissreg on 29.04.2022

  2. Feb 16, 2022

    Change

    Published in Swissreg on 16.02.2022

  3. Apr 7, 2021

    Granted

    Published in Swissreg on 07.04.2021

Parties

Inventor

HIROHASHI, Yoshihiko

Sapporo-shi Hokkaido 060-8556, JP

SAITO, Tsuyoshi

Sapporo-shi Hokkaido 060-8556, JP

OTAKA, Hironori

Ina Nagano 396-0002, JP

TORIGOE, Toshihiko

Sapporo-shi Hokkaido 060-8556, JP

LI, Dongliang

Ina Nagano 396-0002, JP

NAKANO, Kazue

Ina Nagano 396-0002, JP

TOJI, Shingo

Ina Nagano 396-0002, JP

HORIBE, Ryota

Sapporo-shi Hokkaido 060-8556, JP

ATSUYAMA, Eri

Ina Nagano 396-0002, JP

ASANO, Takuya

Sapporo-shi Hokkaido 060-8556, JP

SATO, Noriyuki

Sapporo-shi Hokkaido 060-8556, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.